Neurodegenerative Disorders Drug Development Pipeline Review, 2017

  • ID: 4210126
  • Report
  • Region: Global
  • 797 Pages
  • GBI Research
1 of 5
Over 1,400 Products in Active Development in the Neurodegenerative Disorders Therapy Area

FEATURED COMPANIES

  • AB Science SA
  • Alzhyme Pty Ltd
  • Axon Neuroscience SE
  • Clera Inc.
  • Epigen Biosciences Inc.
  • Impel NeuroPharma Inc.
  • MORE

Summary

Neurodegenerative disorders are a cluster of conditions that affect the central nervous system. They include both hereditary and sporadic conditions that are characterized by slow, irreversible, progressive dysfunction of the nervous system with the increasing degeneration of neurons, which causes symptoms such as motor impairment, memory loss and declining cognitive ability. Neurodegenerative disorders cannot currently be cured, and treatment is aimed at managing the disease indication in order to reduce the severity of symptoms and slow progression.

There are over 1,400 products in active development in the neurodegenerative disorders therapy area. The current market landscape consists of a number of biologics and small molecules, while the pipeline also consists of gene therapies and cell therapies, demonstrating broader pharmaceutical research and development.

Small molecule drugs dominate the pipeline, with approximately 64% of total pipeline molecules. In comparison, the number of biologics in the pipeline is much lower, representing approximately 26% of the pipeline. Overall the neurodegenerative disorders pipeline is large, with a substantial proportion of products being early-stage assets at the Preclinical development stage.

The report provides comprehensive information on the pipeline development landscape for is Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Amyotrophic lateral sclerosis and Multiple sclerosis, from Discovery through to the Pre-registration stage. This includes an analysis of products by stage of development, molecular target, mechanism of action (MoA), route of administration (RoA) and molecule type. Finally, the report provides an overview of key players involved in the development of products in this area, and outlines recent updates and press releases in the field.

Scope

  • Which companies are the most active within the pipeline for neurodegenerative disorders?
  • Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
  • To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
  • What are the most important R&D milestones and data publications to have happened in this disease area?

Reasons to buy

  • Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
  • Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
  • Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
  • Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AB Science SA
  • Alzhyme Pty Ltd
  • Axon Neuroscience SE
  • Clera Inc.
  • Epigen Biosciences Inc.
  • Impel NeuroPharma Inc.
  • MORE

1. Research Report Guidance

2. Executive Summary

3. Introduction

4. Neurodegenerative Disorders Report Coverage

  • Alzheimer's Disease Overview
  • Amyotrophic Lateral Sclerosis Overview
  • Huntington Disease Overview
  • Multiple Sclerosis Overview
  • Parkinson's Disease Overview

5. Therapeutics Development

  • Alzheimer's Disease
  • Amyotrophic Lateral Sclerosis
  • Huntington Disease
  • Multiple Sclerosis
  • Parkinson's Disease

6. Therapeutics under Development by Companies

  • Alzheimer's Disease
  • Amyotrophic Lateral Sclerosis
  • Huntington Disease
  • Multiple Sclerosis
  • Parkinson's Disease

7. Therapeutics under Investigation by Universities/Institutes

  • Alzheimer's Disease
  • Amyotrophic Lateral Sclerosis
  • Huntington Disease
  • Multiple Sclerosis
  • Parkinson's Disease

8. Pipeline Products Glance

  • Alzheimer's Disease
  • Amyotrophic Lateral Sclerosis
  • Huntington Disease
  • Multiple Sclerosis
  • Parkinson's Disease

9. Products under Development by Companies

  • Alzheimer's Disease
  • Amyotrophic Lateral Sclerosis
  • Huntington Disease
  • Multiple Sclerosis
  • Parkinson's Disease

10. Products under Investigation by Universities/Institutes

  • Alzheimer's Disease
  • Amyotrophic Lateral Sclerosis
  • Huntington Disease
  • Multiple Sclerosis
  • Parkinson's Disease

11. Companies Involved in Therapeutics Development

  • Alzheimer's Disease
  • Amyotrophic Lateral Sclerosis
  • Huntington Disease
  • Multiple Sclerosis
  • Parkinson's Disease

12. Therapeutics Assessment

  • Alzheimer's Disease
  • Amyotrophic Lateral Sclerosis
  • Huntington Disease
  • Multiple Sclerosis
  • Parkinson's Disease

13. Dormant Projects

  • Alzheimer's Disease
  • Amyotrophic Lateral Sclerosis
  • Huntington Disease
  • Multiple Sclerosis
  • Parkinson's Disease

14. Discontinued Products

  • Alzheimer's Disease
  • Amyotrophic Lateral Sclerosis
  • Huntington Disease
  • Multiple Sclerosis
  • Parkinson's Disease

15. Product Development Milestones

  • Alzheimer's Disease
  • Amyotrophic Lateral Sclerosis
  • Huntington Disease
  • Multiple Sclerosis
  • Parkinson's Disease

16. Appendix

  • Methodology
  • Coverage
  • Secondary Research
  • Primary Research
  • Expert Panel Validation

List of Tables

  • Number of Products under Development for Alzheimer's Disease
  • Number of Products under Development for Alzheimer's Disease - Comparative Analysis
  • Number of Products under Development for Amyotrophic Lateral Sclerosis
  • Number of Products under Development for Amyotrophic Lateral Sclerosis - Comparative Analysis
  • Number of Products under Development for Huntington Disease
  • Number of Products under Development for Huntington Disease - Comparative Analysis
  • Number of Products under Development for Multiple Sclerosis
  • Number of Products under Development for Multiple Sclerosis - Comparative Analysis
  • Number of Products under Development for Parkinson's Disease
  • Number of Products under Development for Parkinson's Disease - Comparative Analysis
  • Number of Products under Development by Companies Alzheimer's Disease
  • Number of Products under Development by Companies Amyotrophic Lateral Sclerosis
  • Number of Products under Development by Companies Huntington Disease
  • Number of Products under Development by Companies Multiple Sclerosis
  • Number of Products under Development by Companies Parkinson's Disease
  • Number of Products under Investigation by Universities/Institutes Alzheimer's Disease
  • Number of Products under Investigation by Universities/Institutes Amyotrophic Lateral Sclerosis
  • Number of Products under Investigation by Universities/Institutes Huntington Disease
  • Number of Products under Investigation by Universities/Institutes Multiple Sclerosis
  • Number of Products under Investigation by Universities/Institutes Parkinson's Disease
  • Comparative Analysis by Late Stage Development Alzheimer's Disease
  • Comparative Analysis by Clinical Stage Development Alzheimer's Disease
  • Comparative Analysis by Early Stage Development Alzheimer's Disease
  • Comparative Analysis by Unknown Stage Development Alzheimer's Disease
  • Comparative Analysis by Late Stage Development Amyotrophic Lateral Sclerosis
  • Comparative Analysis by Clinical Stage Development Amyotrophic Lateral Sclerosis
  • Comparative Analysis by Early Stage Development Amyotrophic Lateral Sclerosis
  • Comparative Analysis by Unknown Stage Development Amyotrophic Lateral Sclerosis
  • Comparative Analysis by Late Stage Development Huntington Disease
  • Comparative Analysis by Clinical Stage Development Huntington Disease
  • Comparative Analysis by Early Stage Development Huntington Disease
  • Comparative Analysis by Late Stage Development Multiple Sclerosis
  • Comparative Analysis by Clinical Stage Development Multiple Sclerosis
  • Comparative Analysis by Early Stage Development Multiple Sclerosis
  • Comparative Analysis by Unknown Stage Development Multiple Sclerosis
  • Comparative Analysis by Late Stage Development Parkinson's Disease
  • Comparative Analysis by Clinical Stage Development Parkinson's Disease
  • Comparative Analysis by Early Stage Development Parkinson's Disease
  • Comparative Analysis by Unknown Stage Development Parkinson's Disease
  • Products under Development by Companies Alzheimer's Disease
  • Products under Development by Companies Amyotrophic Lateral Sclerosis
  • Products under Development by Companies Huntington Disease
  • Products under Development by Companies Multiple Sclerosis
  • Products under Development by Companies Parkinson's Disease
  • Products under Investigation by Universities/Institutes Alzheimer's Disease
  • Products under Investigation by Universities/Institutes Amyotrophic Lateral Sclerosis
  • Products under Investigation by Universities/Institutes Huntington Disease
  • Products under Investigation by Universities/Institutes Multiple Sclerosis
  • Products under Investigation by Universities/Institutes Parkinson's Disease
  • Alzheimer's Disease - Pipeline by AB Science SA
  • Alzheimer's Disease - Pipeline by AbbVie Inc
  • Alzheimer's Disease - Pipeline by AC Immune SA
  • Alzheimer's Disease - Pipeline by Accera Inc.
  • Alzheimer's Disease - Pipeline by Acelot Inc.
  • Alzheimer's Disease - Pipeline by Actinogen Limited
  • Alzheimer's Disease - Pipeline by Acumen Pharmaceuticals Inc.
  • Alzheimer's Disease - Pipeline by Addex Therapeutics Ltd
  • Alzheimer's Disease - Pipeline by Affibody AB
  • Alzheimer's Disease - Pipeline by AFFiRiS AG
  • Alzheimer's Disease - Pipeline by Alector LLC
  • Alzheimer's Disease - Pipeline by Alkermes Plc
  • Alzheimer's Disease - Pipeline by Allergan Plc
  • Alzheimer's Disease - Pipeline by Allinky Biopharma
  • Alzheimer's Disease - Pipeline by ALSP Inc.
  • Alzheimer's Disease - Pipeline by Alzhyme Pty Ltd
  • Alzheimer's Disease - Pipeline by Alzinova AB
  • Alzheimer's Disease - Pipeline by AlzProtect SAS
  • Alzheimer's Disease - Pipeline by Amarantus Bioscience Holdings Inc.
  • Alzheimer's Disease - Pipeline by Amgen Inc.
  • Alzheimer's Disease - Pipeline by Anavex Life Sciences Corp.
  • Alzheimer's Disease - Pipeline by Aphios Corporation
  • Alzheimer's Disease - Pipeline by Apodemus AB
  • Alzheimer's Disease - Pipeline by Applied Research using OMIC Sciences S.L.
  • Alzheimer's Disease - Pipeline by Araclon Biotech S.L.
  • Alzheimer's Disease - Pipeline by Archer Pharmaceuticals Inc.
  • Alzheimer's Disease - Pipeline by ArmaGen Inc.
  • Alzheimer's Disease - Pipeline by Artery Therapeutics Inc.
  • Alzheimer's Disease - Pipeline by AskAt Inc.
  • Alzheimer's Disease - Pipeline by Astellas Pharma Inc.
  • Alzheimer's Disease - Pipeline by AstraZeneca Plc
  • Alzheimer's Disease - Pipeline by Asubio Pharma Co. Ltd.
  • Alzheimer's Disease - Pipeline by Ausio Pharmaceuticals LLC
  • Alzheimer's Disease - Pipeline by Avineuro Pharmaceuticals Inc.
  • Alzheimer's Disease - Pipeline by Axon Neuroscience SE
  • Alzheimer's Disease - Pipeline by Axovant Sciences Ltd.
  • Alzheimer's Disease - Pipeline by Axsome Therapeutics Inc.
  • Alzheimer's Disease - Pipeline by Axxam SpA
  • Alzheimer's Disease - Pipeline by Beactica AB
  • Alzheimer's Disease - Pipeline by Berg LLC
  • Alzheimer's Disease - Pipeline by BioArctic Neuroscience AB
  • Alzheimer's Disease - Pipeline by Bioasis Technologies Inc.
  • Alzheimer's Disease - Pipeline by Biogen Inc
  • Alzheimer's Disease - Pipeline by Biomar Microbial Technologies
  • Alzheimer's Disease - Pipeline by Bionature E.A. Ltd.
  • Alzheimer's Disease - Pipeline by Boehringer Ingelheim GmbH
  • Alzheimer's Disease - Pipeline by Bristol-Myers Squibb Company
  • Alzheimer's Disease - Pipeline by Bsim2
  • Alzheimer's Disease - Pipeline by Cardax Pharmaceuticals Inc.
  • Alzheimer's Disease - Pipeline by Carna Biosciences Inc.
  • Alzheimer's Disease - Pipeline by Celon Pharma Sp. z o.o.
  • Alzheimer's Disease - Pipeline by CHA Bio & Diostech Co. Ltd.
  • Alzheimer's Disease - Pipeline by Chase Pharmaceuticals Corporation
  • Alzheimer's Disease - Pipeline by Clera Inc.
  • Alzheimer's Disease - Pipeline by Cognition Therapeutics Inc.
  • Alzheimer's Disease - Pipeline by Cognosci Inc.
  • Alzheimer's Disease - Pipeline by CohBar Inc.
  • Alzheimer's Disease - Pipeline by Connexios Life Sciences Pvt. Ltd.
  • Alzheimer's Disease - Pipeline by ContraVir Pharmaceuticals Inc.
  • Alzheimer's Disease - Pipeline by Corium International Inc.
  • Alzheimer's Disease - Pipeline by Coronis Partners Ltd.
  • Alzheimer's Disease - Pipeline by Cortice Biosciences Inc.
  • Alzheimer's Disease - Pipeline by Critical Outcome Technologies Inc.
  • Alzheimer's Disease - Pipeline by Crossbeta Biosciences B.V.
  • Alzheimer's Disease - Pipeline by D-Pharm Ltd.
  • Alzheimer's Disease - Pipeline by Daewoong Pharmaceutical Co. Ltd.
  • Alzheimer's Disease - Pipeline by Daiichi Sankyo Company Limited
  • Alzheimer's Disease - Pipeline by Daval International Limited
  • Alzheimer's Disease - Pipeline by DermaXon LLC
  • Alzheimer's Disease - Pipeline by Dongkook Pharmaceutical Co. Ltd.
  • Alzheimer's Disease - Pipeline by Eisai Co. Ltd.
  • Alzheimer's Disease - Pipeline by Eli Lilly and Company
  • Alzheimer's Disease - Pipeline by Emergent BioSolutions Inc.
  • Alzheimer's Disease - Pipeline by EncephRx Inc.
  • Alzheimer's Disease - Pipeline by Endece LLC
  • Alzheimer's Disease - Pipeline by ENKAM Pharmaceuticals A/S
  • Alzheimer's Disease - Pipeline by Ensemble Therapeutics Corporation
  • Alzheimer's Disease - Pipeline by Ensol Biosciences Inc.
  • Alzheimer's Disease - Pipeline by Epigen Biosciences Inc.
  • Alzheimer's Disease - Pipeline by Euroscreen S.A.
  • Alzheimer's Disease - Pipeline by Evotec AG
  • Alzheimer's Disease - Pipeline by F. Hoffmann-La Roche Ltd.
  • Alzheimer's Disease - Pipeline by FORUM Pharmaceuticals Inc.
  • Alzheimer's Disease - Pipeline by Genentech Inc.
  • Alzheimer's Disease - Pipeline by Genervon Biopharmaceuticals LLC
  • Alzheimer's Disease - Pipeline by GlaxoSmithKline Plc
  • Alzheimer's Disease - Pipeline by GliaCure Inc.
  • Alzheimer's Disease - Pipeline by Glialogix Inc.
  • Alzheimer's Disease - Pipeline by Golden Biotechnology Corp.
  • Alzheimer's Disease - Pipeline by Grifols S.A.
  • Alzheimer's Disease - Pipeline by H. Lundbeck A/S
  • Alzheimer's Disease - Pipeline by Heptares Therapeutics Limited
  • Alzheimer's Disease - Pipeline by HitGen LTD
  • Alzheimer's Disease - Pipeline by Humanetics Corporation
  • Alzheimer's Disease - Pipeline by Ichor Medical Systems Inc.
  • Alzheimer's Disease - Pipeline by Icure Pharmaceutical Inc.
  • Alzheimer's Disease - Pipeline by Immungenetics AG
  • Alzheimer's Disease - Pipeline by Impel NeuroPharma Inc.
  • Alzheimer's Disease - Pipeline by ImStar Therapeutics Inc.
  • Alzheimer's Disease - Pipeline by Inovio Pharmaceuticals Inc.
  • Alzheimer's Disease - Pipeline by IntelGenx Corp.
  • Alzheimer's Disease - Pipeline by Intellect Neurosciences Inc.
  • Alzheimer's Disease - Pipeline by Intra-Cellular Therapies Inc.
  • Alzheimer's Disease - Pipeline by INVENT Pharmaceuticals Inc.
  • Alzheimer's Disease - Pipeline by Io Therapeutics Inc.
  • Alzheimer's Disease - Pipeline by Iproteos S.L.
  • Alzheimer's Disease - Pipeline by Jeil Pharmaceutical Co. Ltd.
  • Alzheimer's Disease - Pipeline by Jiangsu Kanion Pharmaceutical Co. Ltd.
  • Alzheimer's Disease - Pipeline by Johnson & Johnson
  • Alzheimer's Disease - Pipeline by K-Stemcell Co. Ltd.
  • Alzheimer's Disease - Pipeline by Kadmon Corporation LLC
  • Alzheimer's Disease - Pipeline by Kalgene Pharmaceuticals Inc.
  • Alzheimer's Disease - Pipeline by Kareus Therapeutics SA
  • Alzheimer's Disease - Pipeline by KineMed Inc.
  • Alzheimer's Disease - Pipeline by Krenitsky Pharmaceuticals Inc.
  • Alzheimer's Disease - Pipeline by Kyowa Hakko Kirin Co. Ltd.
  • Alzheimer's Disease - Pipeline by Lead Discovery Center GmbH
  • Alzheimer's Disease - Pipeline by Les Laboratoires Servier SAS
  • Alzheimer's Disease - Pipeline by Lipopharma Therapeutics SL
  • Alzheimer's Disease - Pipeline by Living Cell Technologies Limited
  • Alzheimer's Disease - Pipeline by Lupin Limited
  • Alzheimer's Disease - Pipeline by M3 Biotechnology Inc.
  • Alzheimer's Disease - Pipeline by ManRos Therapeutics
  • Alzheimer's Disease - Pipeline by MedDay SA
  • Alzheimer's Disease - Pipeline by Medestea Research & Production S.p.A.
  • Alzheimer's Disease - Pipeline by MedImmune LLC
  • Alzheimer's Disease - Pipeline by Medisyn Technologies Inc.
  • Alzheimer's Disease - Pipeline by MEDRx Co. Ltd.
  • Alzheimer's Disease - Pipeline by Merck & Co. Inc.
  • Alzheimer's Disease - Pipeline by Metabolic Solutions Development Company LLC

List of Figures

  • Number of Products under Development for Alzheimer's Disease
  • Number of Products under Development for Alzheimer's Disease - Comparative Analysis
  • Number of Products under Development for Amyotrophic Lateral Sclerosis
  • Number of Products under Development for Amyotrophic Lateral Sclerosis - Comparative Analysis
  • Number of Products under Development for Huntington Disease
  • Number of Products under Development for Huntington Disease - Comparative Analysis
  • Number of Products under Development for Multiple Sclerosis
  • Number of Products under Development for Multiple Sclerosis - Comparative Analysis
  • Number of Products under Development for Parkinson's Disease
  • Number of Products under Development for Parkinson's Disease - Comparative Analysis
  • Number of Products under Development by Companies Alzheimer's Disease
  • Number of Products under Development by Companies Amyotrophic Lateral Sclerosis
  • Number of Products under Development by Companies Huntington Disease
  • Number of Products under Development by Companies Multiple Sclerosis
  • Number of Products under Development by Companies Parkinson's Disease
  • Number of Products under Investigation by Universities/Institutes Alzheimer's Disease
  • Number of Products under Investigation by Universities/Institutes Amyotrophic Lateral Sclerosis
  • Number of Products under Investigation by Universities/Institutes Huntington Disease
  • Number of Products under Investigation by Universities/Institutes Multiple Sclerosis
  • Number of Products under Investigation by Universities/Institutes Parkinson's Disease
  • Comparative Analysis by Late Stage Development Alzheimer's Disease
  • Comparative Analysis by Clinical Stage Development Alzheimer's Disease
  • Comparative Analysis by Early Stage Products Alzheimer's Disease
  • Comparative Analysis by Late Stage Development Amyotrophic Lateral Sclerosis
  • Comparative Analysis by Clinical Stage Development Amyotrophic Lateral Sclerosis
  • Comparative Analysis by Early Stage Products Amyotrophic Lateral Sclerosis
  • Comparative Analysis by Late Stage Development Huntington Disease
  • Comparative Analysis by Clinical Stage Development Huntington Disease
  • Comparative Analysis by Early Stage Products Huntington Disease
  • Comparative Analysis by Late Stage Development Multiple Sclerosis
  • Comparative Analysis by Clinical Stage Development Multiple Sclerosis
  • Comparative Analysis by Early Stage Products Multiple Sclerosis
  • Comparative Analysis by Late Stage Development Parkinson's Disease
  • Comparative Analysis by Clinical Stage Development Parkinson's Disease
  • Comparative Analysis by Early Stage Products Parkinson's Disease
  • Comparative Analysis by Unknown Stage Development Parkinson's Disease
  • Assessment by Monotherapy Products Alzheimer's Disease
  • Assessment by Combination Products Alzheimer's Disease
  • Number of Products by Top 10 Targets Alzheimer's Disease
  • Number of Products by Stage and Top 10 Targets Alzheimer's Disease
  • Number of Products by Top 10 Mechanism of Actions Alzheimer's Disease
  • Number of Products by Stage and Top 10 Mechanism of Actions Alzheimer's Disease
  • Number of Products by Top 10 Routes of Administration Alzheimer's Disease
  • Number of Products by Stage and Top 10 Routes of Administration Alzheimer's Disease
  • Number of Products by Top 10 Molecule Types Alzheimer's Disease
  • Number of Products by Stage and Top 10 Molecule Types Alzheimer's Disease
  • Assessment by Monotherapy Products Amyotrophic Lateral Sclerosis
  • Assessment by Combination Products Amyotrophic Lateral Sclerosis
  • Number of Products by Top 10 Targets Amyotrophic Lateral Sclerosis
  • Number of Products by Stage and Top 10 Targets Amyotrophic Lateral Sclerosis
  • Number of Products by Top 10 Mechanism of Actions Amyotrophic Lateral Sclerosis
  • Number of Products by Stage and Top 10 Mechanism of Actions Amyotrophic Lateral Sclerosis
  • Number of Products by Top 10 Routes of Administration Amyotrophic Lateral Sclerosis
  • Number of Products by Stage and Top 10 Routes of Administration Amyotrophic Lateral Sclerosis
  • Number of Products by Top 10 Molecule Types Amyotrophic Lateral Sclerosis
  • Number of Products by Stage and Top 10 Molecule Types Amyotrophic Lateral Sclerosis
  • Assessment by Monotherapy Products Huntington Disease
  • Number of Products by Top 10 Targets Huntington Disease
  • Number of Products by Stage and Top 10 Targets Huntington Disease
  • Number of Products by Top 10 Mechanism of Actions Huntington Disease
  • Number of Products by Stage and Top 10 Mechanism of Actions Huntington Disease
  • Number of Products by Top 10 Routes of Administration Huntington Disease
  • Number of Products by Stage and Top 10 Routes of Administration Huntington Disease
  • Number of Products by Top 10 Molecule Types Huntington Disease
  • Number of Products by Stage and Top 10 Molecule Types Huntington Disease
  • Assessment by Monotherapy Products Multiple Sclerosis
  • Number of Products by Top 10 Targets Multiple Sclerosis
  • Number of Products by Stage and Top 10 Targets Multiple Sclerosis
  • Number of Products by Top 10 Mechanism of Actions Multiple Sclerosis
  • Number of Products by Stage and Top 10 Mechanism of Actions Multiple Sclerosis
  • Number of Products by Top 10 Routes of Administration Multiple Sclerosis
  • Number of Products by Stage and Top 10 Routes of Administration Multiple Sclerosis
  • Number of Products by Top 10 Molecule Types Multiple Sclerosis
  • Number of Products by Stage and Top 10 Molecule Types Multiple Sclerosis
  • Assessment by Monotherapy Products Parkinson's Disease
  • Assessment by Combination Products Parkinson's Disease
  • Number of Products by Top 10 Targets Parkinson's Disease
  • Number of Products by Stage and Top 10 Targets Parkinson's Disease
  • Number of Products by Top 10 Mechanism of Actions Parkinson's Disease
  • Number of Products by Stage and Top 10 Mechanism of Actions Parkinson's Disease
  • Number of Products by Top 10 Routes of Administration Parkinson's Disease
  • Number of Products by Stage and Top 10 Routes of Administration Parkinson's Disease
  • Number of Products by Top 10 Molecule Types Parkinson's Disease
  • Number of Products by Stage and Top 10 Molecule Types Parkinson's Disease
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • AB Science SA
  • AC Immune SA
  • AFFiRiS AG
  • ALSP Inc.
  • AbbVie Inc
  • Accera Inc.
  • Acelot Inc.
  • Actinogen Limited
  • Acumen Pharmaceuticals Inc.
  • Addex Therapeutics Ltd
  • Affibody AB
  • Alector LLC
  • Alkermes Plc
  • Allergan Plc
  • Allinky Biopharma
  • AlzProtect SAS
  • Alzhyme Pty Ltd
  • Alzinova AB
  • Amarantus Bioscience Holdings Inc.
  • Amgen Inc.
  • Anavex Life Sciences Corp.
  • Aphios Corporation
  • Apodemus AB
  • Applied Research using OMIC Sciences S.L.
  • Araclon Biotech S.L.
  • Archer Pharmaceuticals Inc.
  • ArmaGen Inc.
  • Artery Therapeutics Inc.
  • AskAt Inc.
  • Astellas Pharma Inc.
  • AstraZeneca Plc
  • Asubio Pharma Co. Ltd.
  • Ausio Pharmaceuticals LLC
  • Avineuro Pharmaceuticals Inc.
  • Axon Neuroscience SE
  • Axovant Sciences Ltd.
  • Axsome Therapeutics Inc.
  • Axxam SpA
  • Beactica AB
  • Berg LLC
  • BioArctic Neuroscience AB
  • Bioasis Technologies Inc.
  • Biogen Inc
  • Biomar Microbial Technologies
  • Bionature E.A. Ltd.
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Bsim2
  • CHA Bio & Diostech Co. Ltd.
  • Cardax Pharmaceuticals Inc.
  • Carna Biosciences Inc.
  • Celon Pharma Sp. z o.o.
  • Chase Pharmaceuticals Corporation
  • Clera Inc.
  • Cognition Therapeutics Inc.
  • Cognosci Inc.
  • CohBar Inc.
  • Connexios Life Sciences Pvt. Ltd.
  • ContraVir Pharmaceuticals Inc.
  • Corium International Inc.
  • Coronis Partners Ltd.
  • Cortice Biosciences Inc.
  • Critical Outcome Technologies Inc.
  • Crossbeta Biosciences B.V.
  • D-Pharm Ltd.
  • Daewoong Pharmaceutical Co. Ltd.
  • Daiichi Sankyo Company Limited
  • Daval International Limited
  • DermaXon LLC
  • Dongkook Pharmaceutical Co. Ltd.
  • ENKAM Pharmaceuticals A/S
  • Eisai Co. Ltd.
  • Eli Lilly and Company
  • Emergent BioSolutions Inc.
  • EncephRx Inc.
  • Endece LLC
  • Ensemble Therapeutics Corporation
  • Ensol Biosciences Inc.
  • Epigen Biosciences Inc.
  • Euroscreen S.A.
  • Evotec AG
  • F. Hoffmann-La Roche Ltd.
  • FORUM Pharmaceuticals Inc.
  • Genentech Inc.
  • Genervon Biopharmaceuticals LLC
  • GlaxoSmithKline Plc
  • GliaCure Inc.
  • Glialogix Inc.
  • Golden Biotechnology Corp.
  • Grifols S.A.
  • H. Lundbeck A/S
  • Heptares Therapeutics Limited
  • HitGen LTD
  • Humanetics Corporation
  • INVENT Pharmaceuticals Inc.
  • Ichor Medical Systems Inc.
  • Icure Pharmaceutical Inc.
  • ImStar Therapeutics Inc.
  • Immungenetics AG
  • Impel NeuroPharma Inc.
  • Inovio Pharmaceuticals Inc.
  • IntelGenx Corp.
  • Intellect Neurosciences Inc.
  • Intra-Cellular Therapies Inc.
  • Io Therapeutics Inc.
  • Iproteos S.L.
  • Jeil Pharmaceutical Co. Ltd.
  • Jiangsu Kanion Pharmaceutical Co. Ltd.
  • Johnson & Johnson
  • K-Stemcell Co. Ltd.
  • Kadmon Corporation LLC
  • Kalgene Pharmaceuticals Inc.
  • Kareus Therapeutics SA
  • KineMed Inc.
  • Krenitsky Pharmaceuticals Inc.
  • Kyowa Hakko Kirin Co. Ltd.
  • Lead Discovery Center GmbH
  • Les Laboratoires Servier SAS
  • Lipopharma Therapeutics SL
  • Living Cell Technologies Limited
  • Lupin Limited
  • M3 Biotechnology Inc.
  • MEDRx Co. Ltd.
  • ManRos Therapeutics
  • MedDay SA
  • MedImmune LLC
  • Medestea Research & Production S.p.A.
  • Medisyn Technologies Inc.
  • Merck & Co. Inc.
  • Metabolic Solutions Development Company LLC
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll